Effect of 1-year, low-dose DHEA therapy on climacteric symptoms and female sexuality

作者: A. R. Genazzani , M. Stomati , V. Valentino , N. Pluchino , E. Potì

DOI: 10.3109/13697137.2011.579649

关键词:

摘要: Background Sexual desire is affected by endocrine and psychosocial factors. Menopausal hormonal changes are relevant to the causes of sexual dysfunction during reproductive aging. Aim To evaluate effects different types replacement therapy (HRT) on function, frequency intercourse, quality relationship in early postmenopausal women. We recruited 48 healthy women aged 50 ‐ 60 years (mean age 54.5 � 3.3 years). Women with climacteric symptoms were uniformly randomized into three groups receiving either dehydroepiandrosterone (DHEA 10 mg) daily, or daily oral estradiol (1 plus dihydrogesterone (5 mg), tibolone (2.5 for 12 months. who refused treated vitamin D (400 IU). Effi cacy was evaluated using McCoy Female Sexuality Questionnaire before treatment after profi le 3, 6 Results The DHEA HRT reported a signifi cant improvement function compared baseline ( p 0.001 0.01, respectively) total score. similar at months treatment. There increases numbers episodes intercourse previous 4 weeks DHEA, comparison value 0.05, respectively). No score occurred D. Conclusions Daily dose mg, all provided

参考文章(33)
Norma L. McCoy, The McCoy Female Sexuality Questionnaire Quality of Life Research. ,vol. 9, pp. 739- 745 ,(2000) , 10.1023/A:1008925906947
PHILIP M. SARREL, Sexuality and menopause. Obstetrics & Gynecology. ,vol. 75, ,(1990) , 10.1097/00006250-199004001-00006
Tommaso Simoncini, Andrea R. Genazzani, Dehydroepiandrosterone, the endothelium, and cardiovascular protection. Endocrinology. ,vol. 148, pp. 3065- 3067 ,(2007) , 10.1210/EN.2007-0424
J. F. MORTOLA, S. S. C. YEN, The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. The Journal of Clinical Endocrinology and Metabolism. ,vol. 71, pp. 696- 704 ,(1990) , 10.1210/JCEM-71-3-696
Jacques Buvat, Androgen therapy with dehydroepiandrosterone World Journal of Urology. ,vol. 21, pp. 346- 355 ,(2003) , 10.1007/S00345-003-0367-7
Susan R. Davis, Sonal M. Shah, Dean P. McKenzie, Jayashri Kulkarni, Sonia L. Davison, Robin J. Bell, Dehydroepiandrosterone Sulfate Levels Are Associated with More Favorable Cognitive Function in Women The Journal of Clinical Endocrinology and Metabolism. ,vol. 93, pp. 801- 808 ,(2008) , 10.1210/JC.2007-2128
Jörgen Nathorst-Böös, Ingela Wiklund, Lars-Åke Mattsson, Kristina Sandin, Bo von Schoultz, Is sexual life influenced by transdermal estrogen therapy?: A double blind placebo controlled study in postmenopausal women Acta Obstetricia et Gynecologica Scandinavica. ,vol. 72, pp. 656- 660 ,(1993) , 10.3109/00016349309021160
Fernand Labrie, David Archer, Céline Bouchard, Michel Fortier, Leonello Cusan, José-Luis Gomez, Ginette Girard, Mira Baron, Normand Ayotte, Michèle Moreau, Robert Dubé, Isabelle Côté, Claude Labrie, Lyne Lavoie, René Bérubé, Patrick Bélanger, Louise Berger, Lucy Gilbert, Céline Martel, John Balser, Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration. Menopause. ,vol. 16, pp. 897- 906 ,(2009) , 10.1097/GME.0B013E31819E8930
Denise von Mühlen, Gail A. Laughlin, Donna Kritz-Silverstein, Elizabeth Barrett-Connor, The Dehydroepiandrosterone And WellNess (DAWN) study: Research design and methods Contemporary Clinical Trials. ,vol. 28, pp. 153- 168 ,(2007) , 10.1016/J.CCT.2006.04.009